FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Amazon Explores AI Content Marketplace With Media Publishers 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
SAN FRANCISCO, April 06, 2018 -- Hagens Berman Sobol Shapiro LLP reminds investors in WageWorks, Inc. (NYSE:WAGE) of the May 8, 2018 Lead Plaintiff deadline in the pending securities class action. If you purchased or otherwise acquired securities of WageWorks between May 5, 2016 and March 1, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information, visit:
https://www.hbsslaw.com/cases/WAGE
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On March 1, 2018, WageWorks announced “it is delaying its Annual Report on Form 10K for the year ended December 31, 2017 and its financial results and associated conference call for the fourth quarter of 2017.”
This news drove the price of WageWorks shares down $9.75, or nearly 19%, to close at $42.70 on March 1, 2018.
The next day, Defendants explained the Company’s audit committee is investigating WageWorks’s revenue recognition during fiscal 2016 and the investigation may result “in the identification of other accounting issues, further material weaknesses, and/or require the restatement of the Company’s financial statements for previous periods.”
In addition, SEC filings show WageWorks’s CEO sold approximately $34 million of his shares during June 2017.
“We’re focused on Defendants’ compliance with generally accepted accounting principles, whether the CEO’s sales were improper, and investors’ losses,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding WageWorks should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000
